首页> 外国专利> Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans

Vaccine against dental caries based on virulence-associated immunomodulatory extracellular proteins produced by the cariogenic bacteria Streptococcus sobrinus and Streptococcus mutans

机译:基于致龋菌链球菌变形链球菌产生的毒力相关免疫调节细胞外蛋白的龋齿疫苗

摘要

This invention is concerned with a vaccine against dental caries obtained from the supernatant over cultures of the cariogenic bacteria Streptococcus sobrinus and S. mutans that consists of extracellular proteins. These proteins provide the suppression of the immune response in the host through the early production of IL-10, an anti-inflammatory cytokine and are, for that reason, virulent factors to the microorganism enhancing bacterial load in the host. These proteins were designated as virulence-associated immunomodulatory extracellular proteins (VIP). Vaccination through the host immunization with active VIP in a submitogenis dose, inactivated VIP or enolase in a dose unable to induce immunosuppression, induces the immunoneutralization of the VIP immunobiological effects.;Vaccination can be used both as a preventive or therapeutic measure of dental caries as long as it is administered (intranasally, orally or subcutaneously) into mammals before or after bacterial infection, respectively.
机译:本发明涉及一种由龋齿细菌链球菌 S的培养物从上清液中获得的抗龋齿疫苗。由细胞外蛋白组成的变异。这些蛋白质通过早期产生抗炎性细胞因子IL-10抑制宿主的免疫反应,因此,它们是微生物的毒性因子,可增强宿主的细菌负荷。这些蛋白被称为与毒性相关的免疫调节细胞外蛋白(VIP)。通过呈递剂量的活性VIP进行宿主免疫,不能诱导免疫抑制的剂量的灭活VIP或烯醇酶进行宿主免疫可以诱导VIP免疫生物学效应的免疫中和作用;只要将其分别在细菌感染之前或之后(鼻内,口服或皮下)施用于哺乳动物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号